Cardiologists to highlight features of InfraReDx’ LipiScan Coronary Imaging Program at ACC.10 and i2 Summit InfraReDx, Inc. The meeting, named ACC http://letadalafil.net . InfraReDx’s LipiScan near-infrared spectroscopy catheter is the only FDA-cleared product to detect and assess the intracoronary composition of lipid primary plaque, which cannot be detected by used diagnostic tests such as for example treadmill exams and coronary angiograms commonly. Lipid core-made up of plaque is believed to be ‘vulnerable plaque’ that can rupture and form dangerous blood clots leading to coronary thrombosis. LCP can be widely considered to be responsible for a substantial number of stenting treatment complications and is believed to be the root cause of acute coronary occasions, the leading cause of death in the developed world.